Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
987 studies found for:    Interferon alfa-2 OR Roferon-A (2a), Intron A (2b)[TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
1 Completed Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C
Condition: Hepatitis C
Intervention: Drug: Pegylated interferon alfa-2a
2 Active, not recruiting Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia
Conditions: Conjunctival Intraepithelial Neoplasia;   Corneal Intraepithelial Neoplasia
Interventions: Drug: Mitomycin C;   Drug: Interferon Alfa-2b
3 Completed
Has Results
Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma
Condition: Melanoma
Interventions: Drug: Bortezomib;   Drug: Interferon Alfa-2b
4 Completed Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery
Conditions: Recurrent Melanoma;   Recurrent Renal Cell Cancer;   Stage III Melanoma;   Stage IV Melanoma;   Stage IV Renal Cell Cancer
Interventions: Biological: recombinant interferon alfa-2b;   Drug: amifostine/azacitidine
5 Active, not recruiting Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma
Condition: Melanoma
Interventions: Drug: High-dose Interferon alfa-2b;   Drug: Vemurafenib
6 Completed
Has Results
Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus
Condition: Hepatitis C, Chronic
Interventions: Drug: Peg-Interferon Alpha-2A;   Drug: Ribavirin
7 Terminated
Has Results
Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Interventions: Drug: Decitabine;   Drug: Interferon Alfa-2b
8 Terminated Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer
Conditions: Breast Cancer;   Metastatic Cancer
Interventions: Biological: PEG-interferon alfa-2a;   Drug: Capecitabine
9 Active, not recruiting Recombinant Interferon Alfa-2b in Treating Patients With Melanoma
Conditions: Stage IA Skin Melanoma;   Stage IB Skin Melanoma;   Stage IIA Skin Melanoma;   Stage IIB Skin Melanoma;   Stage IIC Skin Melanoma;   Stage IIIA Skin Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma
Interventions: Biological: recombinant interferon alfa-2b;   Other: laboratory biomarker analysis
10 Recruiting Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas
Conditions: Lymphoma, T-Cell, Cutaneous;   Mycosis Fungoides
Interventions: Drug: Methotrexate;   Drug: Interferon Alfa-2b
11 Recruiting A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Lamivudine;   Drug: Pegylated Interferon Alfa-2A
12 Completed Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced Neoplasm
Condition: Advanced Neoplasm
Intervention: Drug: Vinorelbine, Cyclophosphamide and Interferon alpha 2b
13 Completed Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
Conditions: Metastatic Gastrointestinal Carcinoid Tumor;   Recurrent Gastrointestinal Carcinoid Tumor;   Regional Gastrointestinal Carcinoid Tumor
Interventions: Biological: PEG-interferon alfa-2b;   Biological: bevacizumab;   Other: laboratory biomarker analysis
14 Completed
Has Results
A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols
Condition: Hepatitis C, Chronic
Interventions: Drug: Pegylated-interferon alfa-2a;   Drug: Ribavirin
15 Active, not recruiting Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell Carcinoma
Condition: Advanced Renal Cell Carcinoma
Intervention: Drug: Pazopanib + interferon alpha 2A
16 Withdrawn Study to Evaluate Sodium Stibogluconate With Interferon Alpha-2b
Conditions: Advanced Cancer;   Solid Tumors
Interventions: Drug: Sodium Stibogluconate;   Drug: Interferon Alpha-2b
17 Recruiting Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Chinese Healthy Volunteers
Condition: Healthy
Interventions: Biological: Human Serum Albumin/interferon alpha2b;   Biological: Peginterferon 180 μg single dose S.C.
18 Completed Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase I Study in Chinese Healthy Volunteers
Condition: Healthy Volunteers
Interventions: Biological: Human Serum Albumin/interferon alpha2a 300-1200 mcg single dose S.C.;   Biological: Peginterferon 180 mcg single dose S.C.
19 Completed
Has Results
Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon alfa-2a and ribavirin;   Drug: Peginterferon alfa-2a
20 Terminated
Has Results
Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer
Condition: Cervical Cancer
Interventions: Biological: recombinant interferon alpha-2b;   Drug: isotretinoin;   Drug: paclitaxel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.